Syros Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SYRS and buy or sell other stocks, ETFs, and their options commission-free!About SYRS
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609.
CEONancy A. Simonian
CEONancy A. Simonian
Employees124
Employees124
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2011
Founded2011
Employees124
Employees124
SYRS Key Statistics
Market cap25.20K
Market cap25.20K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume5.31M
Average volume5.31M
High today—
High today—
Low today—
Low today—
Open price$0.0004
Open price$0.0004
Volume0.00
Volume0.00
52 Week high$5.22
52 Week high$5.22
52 Week low$0.65
52 Week low$0.65
Stock Snapshot
With a market cap of 25.2K, Syros Pharmaceuticals(SYRS) trades at $0.00.
On 2026-10-28, Syros Pharmaceuticals(SYRS) shares started trading at $0.00, with intraday highs of — and lows of —.
Trading volume for Syros Pharmaceuticals(SYRS) stock has reached 0, versus its average volume of 5.31M.
The stock's 52-week range extends from a low of $0.65 to a high of $5.22.
The stock's 52-week range extends from a low of $0.65 to a high of $5.22.
People also own
Based on the portfolios of people who own SYRS. This list is generated using Robinhood data, and it’s not a recommendation.